WASHINGTON (dpa-AFX) - Actavis, Inc. (ACT), on Tuesday said that the
United States Court of Appeals for the Federal Circuit dismissed a decision by a United States District Court, labeling the company's generic contraceptive and anti-Acne drug Vestura, ...
[Published FinanzNachrichten.de - Apr 16 2013]